Gene therapy - promises, problems and prospects

被引：1437

作者：

Verma, IM

Somia, N

机构：

[1] Laboratory of Genetics, Salk Inst. for Biological Studies, San Diago

来源：

NATURE | 1997年 / 389卷 / 6648期

关键词：

D O I：

10.1038/38410

中图分类号：

O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

In principle, gene therapy is simple: putting corrective genetic material into cells alleviates the symptoms of disease. In practice, considerable obstacles have emerged. But, thanks to better delivery systems, there is hope that the technique will succeed.

引用

收藏

页码：239 / 242

页数：4

相关论文

共 30 条

[1] SEMLIKI FOREST VIRUS EXPRESSION SYSTEM - PRODUCTION OF CONDITIONALLY INFECTIOUS RECOMBINANT PARTICLES [J].

BERGLUND, P ;

SJOBERG, M ;

GAROFF, H ;

ATKINS, GJ ;

SHEAHAN, BJ ;

LILJESTROM, P .

BIO-TECHNOLOGY, 1993, 11 (08) :916-920

[2] T-LYMPHOCYTE-DIRECTED GENE-THERAPY FOR ADA(-) SCID - INITIAL TRIAL RESULTS AFTER 4 YEARS [J].

BLAESE, RM ;

CULVER, KW ;

MILLER, AD ;

CARTER, CS ;

FLEISHER, T ;

CLERICI, M ;

SHEARER, G ;

CHANG, L ;

CHIANG, YW ;

TOLSTOSHEV, P ;

GREENBLATT, JJ ;

ROSENBERG, SA ;

KLEIN, H ;

BERGER, M ;

MULLEN, CA ;

RAMSEY, WJ ;

MUUL, L ;

MORGAN, RA ;

ANDERSON, WF .

SCIENCE, 1995, 270 (5235) :475-480

[3]

Blomer U, 1997, J VIROL, V71, P6641

[4] GENE-THERAPY IN PERIPHERAL-BLOOD LYMPHOCYTES AND BONE-MARROW FOR ADA(-) IMMUNODEFICIENT PATIENTS [J].

BORDIGNON, C ;

NOTARANGELO, LD ;

NOBILI, N ;

FERRARI, G ;

CASORATI, G ;

PANINA, P ;

MAZZOLARI, E ;

MAGGIONI, D ;

ROSSI, C ;

SERVIDA, P ;

UGAZIO, AG ;

MAVILIO, F .

SCIENCE, 1995, 270 (5235) :470-475

[5] Persistence in muscle of an adenoviral vector that lacks all viral genes [J].

Chen, HH ;

Mack, LM ;

Kelly, R ;

Ontell, M ;

Kochanek, S ;

Clemens, PR .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (05) :1645-1650

[6] TRANSFER OF GENES TO HUMANS - EARLY LESSONS AND OBSTACLES TO SUCCESS [J].

CRYSTAL, RG .

SCIENCE, 1995, 270 (5235) :404-410

[7] GENE-THERAPY VIA PRIMARY MYOBLASTS - LONG-TERM EXPRESSION OF FACTOR-IX PROTEIN FOLLOWING TRANSPLANTATION INVIVO [J].

DAI, Y ;

ROMAN, M ;

NAVIAUX, RK ;

VERMA, IM .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (22) :10892-10895

[8] CELLULAR AND HUMORAL IMMUNE-RESPONSES TO ADENOVIRAL VECTORS CONTAINING FACTOR-IX GENE - TOLERIZATION OF FACTOR-IX AND VECTOR ANTIGENS ALLOWS FOR LONG-TERM EXPRESSION [J].

DAI, YF ;

SCHWARZ, EM ;

GU, DL ;

ZHANG, WW ;

SARVETNICK, N ;

VERMA, IM .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (05) :1401-1405

[9]

Danks D.M., 1989, JAPANESE J HUMAN GEN, V34, P253

[10] ABLATION OF E2A IN RECOMBINANT ADENOVIRUSES IMPROVES TRANSGENE PERSISTENCE AND DECREASES INFLAMMATORY RESPONSE IN MOUSE-LIVER [J].

ENGELHARDT, JF ;

YE, XH ;

DORANZ, B ;

WILSON, JM .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (13) :6196-6200